When we compared the correlations between MYB expression and its targets in the 2KR-MYB set that are also defined as direct 2KR-MYB targets (Fig. 3A), we observed even stronger correlations, 87.3%, 91.0%, and 89.7% in the LAML, BRCA, and COAD cancer cohorts, respectively (Fig. 4J). This evidence concerns the gene MYB and colon adenocarcinoma.